Echographic Measurement of Skin Thickness
1 other identifier
observational
100
1 country
1
Brief Summary
To optimize a medical device for intradermal injection, knowledge concerning the thickness of epidermis and dermis at the proximal forearm is required. Since scientific knowledge is lacking, the investigators will examine the skin thickness (epidermis and dermis) of adults using imaging technology (High Frequency Ultrasound). The investigators hypothesize that they are able to correlate the thickness of the (epi)dermis to a specific combination of parameters age, gender, and BMI. Based on these results, the investigators can define which needle type and length is needed to correctly perform injections into the dermal layer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 4, 2015
CompletedFirst Posted
Study publicly available on registry
February 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedOctober 6, 2015
October 1, 2015
5 months
February 4, 2015
October 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
skin thickness (in milimeters) of the proximal forearm dorsal (both left and right)
10 minutes
skin thickness (in milimeters) of the proximal forearm ventral (both left and right)
10 minutes
skin thickness (in milimeters) of the deltoid region (both left and right)
10 minutes
Secondary Outcomes (3)
Body Mass Index
at the moment of entering the study
Age
at the moment of entering the study
sex
at the moment of entering the study
Study Arms (4)
Participants aged 18-30 years
Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 18-30 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female
Participants aged 31-40 years
Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 31-40 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female
Participants aged 41-50 years
Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 41-50 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female
Participants aged 51-65 years
Echographic measurement of skin thickness at the proximal forearm and the deltoid region in participants aged 51-65 years. aimed number: 12 male \& 12 female maximum number: 15 male \& 15 female
Interventions
(Epi)Dermal thickness at the proximal forearm and the deltoid region will be measured using imaging technology, more specifically high-frequency ultrasound (20-40 MHz) in B-mode (VEVO 2100®, Visual Sonics). This non-invasive measuring technique has already been proven to be accurate. The echographic measurement will be performed on the left and right deltoid region and on two sides of the proximal forearm. Both the dorsal part and the volar/palmar part of the proximal forearm will be investigated. Ultrasound will be executed using gel (Aquasonic®) to optimize imaging.
Eligibility Criteria
Participants will be recruited in the vicinity of the university and its university hospital of Antwerp, in the period of January 2015 until April 2015.
You may qualify if:
- Healthy adults
- Age: 18-65 years
- Dutch-speaking
- Caucasian
You may not qualify if:
- Pregnancy or lactating
- Using ointment, crème, or gels based on corticoids
- Suffering from skin diseases (psoriasis, burning wounds)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Novosanis NVlead
Study Sites (1)
Department of Pharmaceutical Sciences; Laboratory of Physiopharmacology; University of Antwerp; Campus Drie Eiken
Wilrijk, Antwerp, 2610, Belgium
Related Publications (1)
Van Mulder TJ, de Koeijer M, Theeten H, Willems D, Van Damme P, Demolder M, De Meyer G, Beyers KC, Vankerckhoven V. High frequency ultrasound to assess skin thickness in healthy adults. Vaccine. 2017 Mar 27;35(14):1810-1815. doi: 10.1016/j.vaccine.2016.07.039. Epub 2016 Aug 3.
PMID: 27496276DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa Vankerckhoven, PhD
CEO
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2015
First Posted
February 16, 2015
Study Start
January 1, 2015
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
October 6, 2015
Record last verified: 2015-10